Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture
Clinical trial NCT05116930 · RECRUITING
Trial details
- NCT number
- NCT05116930
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-19
- Primary completion
- 2027-12-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.